Skip to Content
Find More Like This
Return to Search

Id-1 and Id-2 genes and products as therapeutic targets for treatment of breast cancer and other types of carcinoma

United States Patent

8,846,629
September 30, 2014
View the Complete Patent at the US Patent & Trademark Office
Lawrence Berkeley National Laboratory - Visit the Technology Transfer and Intellectual Property Management Department Website
A method for treatment and amelioration of breast, cervical, ovarian, endometrial, squamous cells, prostate cancer and melanoma in a patient comprising targeting Id-1 or Id-2 gene expression with a delivery vehicle comprising a product which modulates Id-1 or Id-2 expression.
Desprez; Pierre-Yves (Richmond, CA), Campisi; Judith (Berkeley, CA)
The Regents of the University of California (Oakland, CA), California Pacific Medical Center Research Institute (San Francisco, CA)
12/ 326,832
20090180988
December 2, 2008
STATEMENT OF GOVERNMENTAL SUPPORT This invention was made with government support under Contract No. DE-AC03-76SF00098, now Contract No. DE-AC02-05CH11231, awarded by the United States Department of Energy, and under NIH Grant for NCI RO1CA82548. The Government has certain rights in this invention.